Global Health Impact Costello Medical is an award-winning, employee-owned global healthcare agency with expertise in Medical Communications, HEOR, Evidence Development, and Market Access, serving pharmaceutical and MedTech clients across Europe, US, Canada, and Asia Pacific. This presents opportunities to upsell integrated services, especially for multiregional trials and global HTA submissions.

Pro Bono Prestige The firm delivers extensive pro bono support to charities and non-profits, including collaborations with Heartburn Cancer UK and rare disease organizations. This demonstrates a strong corporate social responsibility story and potential entry points for funded partnerships, grant-backed projects, and government-funded health initiatives.

Awarded Growth Recent recognitions including the King’s Award for Enterprise in International Trade and PMi Agency of the Year reflect strong international growth, quality, and reputation. This credibility can be leveraged to pursue larger, multi-region contracts and partnerships with global pharma and MedTech players seeking reliable agencies.

Tech-Forward Capabilities Utilizes a modern tech stack (SAS, Tableau, Azure AD, iCIMS, HubSpot, DocuSign, Microsoft Sentinel) to support data analytics, health economics, and regulatory/commercial processes. This positions Costello Medical to offer data-driven HEOR and market access solutions with scalable implementation for clients adopting digital health strategies.

Growth Focus Areas Strong focus on Rare Diseases and MedTech, plus expertise in Health Policy and Public Affairs, indicates cross-sell potential into niche therapeutic areas, diagnostics, and digital health. Sales opportunities exist in expanding HTA submissions, real-world evidence programs, and patient engagement initiatives for emerging technologies.